WEDNESDAY, Dec. 4, 2024 (HealthDay News) — Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. “Given the increased interest around obesity medications, we conducted this study to help health care providers and patients makeContinue Reading

WEDNESDAY, Dec. 4, 2024 (Healtday News) — An investigation into an E. coli outbreak linked to McDonald’s Quarter Pounders has officially been closed, the U.S. Food and Drug Administration announced Tuesday. In total, 104 people from 14 states were sickened and 34 were hospitalized during the outbreak, while one olderContinue Reading